证券记录 · 已归档季度
ATRC
AtriCure, Inc. · Healthcare · Medical - Instruments & Supplies
16被追踪持有人
-1Δ持有人
18.32M持有股份
$600.37M报告持仓市值
+0新建仓位
−1清仓
动量输入(同类管理人):
持有人广度 -5.9% ·
股份流向 +13.3% ·
净新建仓位 -6.2%
· 公式
集中增持:持股数量上升,持有人数量减少
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | +3 | 35.69M | $1.00B | +9 | −7 |
| Q1 2026 | 100 | +5 | 35.01M | $1.03B | +10 | −6 |
| Q4 2025 | 96 | +1 | 36.16M | $1.43B | +2 | n/a |
| Q3 2025 | 17 | -1 | 19.38M | $683.04M | n/a | −2 |
| Q2 2025 | 16 | -1 | 18.32M | $600.37M | n/a | −1 |
| Q1 2025 | 14 | 0 | 6.98M | $225.02M | +1 | −1 |
| Q4 2024 | 14 | +1 | 5.72M | $174.87M | +2 | −1 |
| Q3 2024 | 12 | -1 | 4.89M | $137.07M | n/a | −1 |
| Q2 2024 | 13 | n/a | 5.61M | $127.65M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 4.91M | n/a | $160.78M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (被动) | 4.02M | n/a | $131.82M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 3 | Wellington Management ✦ | 3.97M | +465.4% | $130.07M | 0.0% | ▲ Add | 5 | SEC ↗ ×6 |
| 4 | State Street Global Advisors ✦ (被动) | 1.27M | -0.4% | $41.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.18M | +1.2% | $38.73M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Marshall Wace ✦ | 1.01M | +1.1% | $32.94M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 7 | Two Sigma Investments ✦ | 411.91K | -38.3% | $13.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 377.70K | +22.7% | $12.38M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Millennium Management ✦ | 360.06K | -42.2% | $11.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 275.00K | 0.0% | $9.01M | 0.0% | Held | 3 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 270.29K | n/a | $8.86M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 12 | Citadel Advisors ✦ | 134.74K | -28.9% | $4.42M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 67.71K | -19.1% | $2.22M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 14 | T. Rowe Price ✦ | 46.31K | +6.5% | $1.52M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Norges Bank ✦ (被动) | 10.44K | -82.3% | $342,053 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 7.78K | -69.3% | $254,820 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Point72 Asset Management | $18.01M | 曾为 0.1% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 221 持有人, 49.84M 股份, $1.41B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 23
Privitera Salvatore
Officer · 4.52K 股 · $271,140
Sep 11
GROVES REGINA E
Director · 5.31K 股 · $288,071
Sep 08
Privitera Salvatore
Officer · 3.66K 股 · $201,135
Sep 02
Privitera Salvatore
Officer · 7.76K 股 · $407,558
Aug 24
Dahlquist Karl S.
Officer · 9.37K 股 · $458,099
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Oct 05
SC 13G/A: BlackRock, Inc.
Aug 14
SC 13G/A: ALLIANCEBERNSTEIN L.P.
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据